TipRanks
Ceryvyn Therapeutics Limited (CYVNY)
OTHER OTC:CYVNY
US Market
Want to see CYVNY full AI Analyst Report?

Ceryvyn Therapeutics Limited (CYVNY) Financial Statements

191 Followers

Ceryvyn Therapeutics Limited Financial Overview

Ceryvyn Therapeutics Limited's market cap is currently $9.62M. The company's EPS TTM is $-4.16; its P/E ratio is -1.16; Ceryvyn Therapeutics Limited is scheduled to report earnings on August 28, 2026, and the estimated EPS forecast is $0.00. See an overview of income statement, balance sheet, and cash flow financials.
Jun 24Jun 23Jun 22Jun 21Jun 20
Income Statement
Total Revenue$ 124.67K$ 161.16K$ 125.05K$ 91.98KAU$ 145.90K
Gross Profit$ 21.72K$ -89.31K$ -107.42K$ -480.00KAU$ -371.37K
Operating Income$ -191.84M$ -223.45M$ -133.27M$ -53.18MAU$ -24.70M
EBITDA$ -200.02M$ -223.30M$ -99.01M$ -50.14MAU$ -24.92M
Net Income$ -220.24M$ -211.88M$ -127.99M$ -60.79MAU$ -16.12M
Balance Sheet
Cash & Short-Term Investments$ 172.47M$ 133.99M$ 64.90M$ 157.43MAU$ 62.02M
Total Assets$ 188.79M$ 148.19M$ 87.32M$ 184.36MAU$ 71.89M
Total Debt$ 141.65M$ 272.98K$ 0.00$ 150.47KAU$ 265.08K
Net Debt$ -30.82M$ -133.71M$ -64.90M$ -157.28MAU$ -61.76M
Total Liabilities$ 264.60M$ 156.98M$ 17.55M$ 4.16MAU$ 7.08M
Stockholders' Equity$ -75.81M$ -8.79M$ 69.77M$ 180.20MAU$ 64.81M
Cash Flow
Free Cash Flow$ -161.05M$ -179.34M$ -98.39M$ -61.08M-
Operating Cash Flow$ -161.02M$ -179.30M$ -98.37M$ -61.06MAU$ -8.24M
Investing Cash Flow$ -33.49K$ -32.64K$ -23.32K$ 880.07KAU$ 482.83K
Financing Cash Flow$ 243.73M$ 248.70M$ 236.62K$ 156.76MAU$ 48.06M

Ceryvyn Therapeutics Limited Earnings and Revenue History

Ceryvyn Therapeutics Limited Debt to Assets

Ceryvyn Therapeutics Limited Cash Flow

Ceryvyn Therapeutics Limited Forecast EPS vs Actual EPS